A Review of Antihypertensive Drugs and Choosing the Right Antihypertensive for Recurrent Stroke Prevention

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-29152-9_14
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging cardiovascular indications of mineralocorticoid receptor antagonists.

  2015cited by this paper
• Lowering of Blood Pressure for Recurrent Stroke Prevention

  2014cited by this paper
• Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

  2014cited by this paper
• A Prospective Evaluation of Labetalol Versus Nicardipine for Blood Pressure Management in Patients with Acute Stroke

  2013cited by this paper
• Rationale for Fixed-Dose Combinations in the Treatment of Hypertension

  2012cited by this paper
• Does achieving an intensive versus usual blood pressure level prevent stroke?

  2012cited by this paper
• Cerebral Autoregulation in Stroke: A Review of Transcranial Doppler Studies

  2010cited by this paper
• Doxazosin in the current treatment of hypertension

  2008cited by this paper
• Do pleiotropic effects of antihypertensive medications exist or is it all about the blood pressure?

  2008cited by this paper
• Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.

  2007cited by this paper
• Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure

  2006cited by this paper
• Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

  2005cited by this paper
• Pharmacotherapy Review: Angiotensin Receptor Antagonists

  2005cited by this paper
• Calcium Channel Blocker Class Heterogeneity: Select Aspects of Pharmacokinetics and Pharmacodynamics

  2005cited by this paper
• Home blood pressure measurement: a systematic review.

  2005cited by this paper
• Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.

  2005cited by this paper
• Transdermal Clonidine: Therapeutic Considerations

  2005cited by this paper
• Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension

  2005cited by this paper
• Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis

  2005cited by this paper
• Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.

  2004cited by this paper
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

  2004cited by this paper
• A likely explanation for the J-curve of blood pressure cardiovascular risk.

  2004cited by this paper
• Diuretic Versus &agr;-Blocker as First-Step Antihypertensive Therapy: Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  2003cited by this paper
• Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review

  2003cited by this paper
• The J-curve in hypertension

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.

  2003cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

  2003cited by this paper
• Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.

  2003cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack.

  2003cited by this paper
• Do thiazide diuretics confer specific protection against strokes?

  2003cited by this paper
• Income inequality and population health

  2002cited by this paper
• Use of ramipril in preventing stroke: double blind randomised trial

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

  2001cited by this paper
• Cardiovascular protection and blood pressure reduction: a meta-analysis.

  2001cited by this paper
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

  2000cited by this paper
• ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

  2000cited by this paper
• Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

  1999cited by this paper
• Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

  1997cited by this paper
• Post-stroke antihypertensive treatment study. A preliminary result

  1995cited by this paper
• Atenolol in Secondary Prevention after Stroke

  1995cited by this paper
• Trial of Secondary Prevention With Atenolol After Transient Ischemic Attack or Nondisabling Ischemic Stroke

  1993cited by this paper
• The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?

  1991cited by this paper
• The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.

  1990cited by this paper
• Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction.

  1988cited by this paper
• Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly.

  1986cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects

  2019cites this paper